2 results
Approved WMOPending
Primary:To assess the safety and tolerability of DS-1211b compared with placebo in subjects with PXE.To assess the dose response by assessing the treatment changes in PD endpoints.
Approved WMOPending
To evaluate the dose-response relationship of SVT-404776 on efficacy.